JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Buu-Khanh Lam
Paul Hendry
Marc Ruel
Roy Masters
Fraser Rubens
Thierry Mesana
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lam, B.-K.
Right arrow Articles by Mesana, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lam, B.-K.
Right arrow Articles by Mesana, T.
Related Collections
Right arrowRelated Articles

J Thorac Cardiovasc Surg 2007;133:1464-1473
© 2007 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

The impact of patient–prosthesis mismatch on late outcomes after mitral valve replacement

Buu-Khanh Lam, MD*, Vincent Chan, MD, Paul Hendry, MD, Marc Ruel, MD, Roy Masters, MD, Pierre Bedard, MD, Bill Goldstein, MD, Fraser Rubens, MD, Thierry Mesana, MD

Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Read at the Eighty-sixth Annual Meeting of The American Association for Thoracic Surgery, April 29–May 2, 2006, Philadelphia, Pa.

Received for publication May 29, 2006; revisions received November 28, 2006; accepted for publication December 12, 2006.

* Address for reprints: Buu-Khanh Lam, MDCM, Division of Cardiac Surgery, University of Ottawa Heart Institute, 40 Ruskin St, H3404, Ontario, Canada K1Y 4W7. (Email: bklam{at}ottawaheart.ca).

Objectives: The incidence of patient–prosthesis mismatch after mitral valve replacement and its effect on late outcomes have remained unclear. This study was conducted to determine the impact of patient–prosthesis mismatch on recurrent congestive heart failure, postoperative pulmonary hypertension, and late survival after mitral valve replacement.

Methods: Between 1985 and 2005, 884 patients, with a mean age 63 ± 12 years, underwent mitral valve replacement (657 mechanical, 227 bioprosthesis) with contemporary prostheses. Mean clinical and echocardiographic follow-up was 5.1 ± 4.1 years (4344 patient-years). Patient–prosthesis mismatch was defined as an indexed effective orifice area of 1.25 cm2/m2 or less. Parametric and nonparametric analyses were used to determine predictors of outcomes.

Results: The incidence of patient–prosthesis mismatch was 32%. Predictors of recurrent congestive heart failure included low indexed effective orifice area, low ejection fraction, elevated postoperative mean mitral gradient, and use of a bioprosthesis (P ≤ .05). Postoperative pulmonary hypertension was associated with small mitral size, elevated mean mitral gradient, low ejection fraction, and atrial fibrillation (P ≤ .05); indexed effective orifice area did not predict postoperative pulmonary hypertension (P = .89). Poor late survival was predicted by low indexed effective orifice area (≤1.25 cm2/m2), New York Heart Association class 3 or 4, elevated right ventricular pressure, stroke, older age, coronary artery disease, and bioprosthesis use (P ≤ .05). Survival for patients with patient–prosthesis mismatch versus those without patient–prosthesis mismatch at 1, 3, 5, and 10 years was 91% versus 95%, 85% versus 90%, 78% versus 86%, and 65% versus 75%, respectively (P = .05).

Conclusions: Patient–prosthesis mismatch after mitral valve replacement is not uncommon; it is associated with recurrence of congestive heart failure and postoperative pulmonary hypertension and independently affected late survival. This study emphasizes the importance of implanting a sufficiently large prosthesis in adult patients undergoing mitral valve replacement.

Abbreviations and Acronyms EOA = effective orifice area; GOA = geometric orifice area; IEOA = indexed effective orifice area; IGOA = indexed geometric orifice area; MVPPM = mitral valve patient–prosthesis mismatch; MVR = mitral valve replacement; PHTN = pulmonary hypertension; PPM = patient–prosthesis mismatch; RVSP = right ventricular systolic pressure; SPAP = systolic pulmonary artery pressure


Related Articles

Prosthesis–patient mismatch in the mitral position: Old concept, new evidences
Philippe Pibarot and Jean G. Dumesnil
J. Thorac. Cardiovasc. Surg. 2007 133: 1405-1408. [Extract] [Full Text] [PDF]

Discussion
J. Thorac. Cardiovasc. Surg. 2007 133: 1472-1473. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.